Hyperimmune immunoglobulin for people with COVID-19
Kimber C., Valk SJ., Chai KL., Piechotta V., Iannizzi C., Monsef I., Wood EM., Lamikanra AA., Roberts DJ., McQuilten Z., So-Osman C., Estcourt LJ., Skoetz N.
Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. Using a living systematic review approach, to assess whether hyperimmune immunoglobulin therapy is effective and safe in the treatment of people with COVID-19; and to maintain the currency of the evidence.